Very Poor Long-Term Survival in Past and More Recent Studies for Relapsed AML Patients: The ECOG-ACRIN Experience

American Journal of Hematology - United States
doi 10.1002/ajh.25162
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Wiley

Related search

Expression of S100A8 in Leukemic Cells Predicts Poor Survival in De Novo AML Patients

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2010English

Very Long-Term Survival Patterns of Young Patients Treated With Radical Prostatectomy for High-Risk Prostate Cancer

Urologic Oncology: Seminars and Original Investigations
OncologyUrology
2016English

Allogeneic Hemopoietic Stem Cell Transplants for Patients With Relapsed Acute Leukemia: Long-Term Outcome

Bone Marrow Transplantation
TransplantationHematology
2007English

MS18.01 Treatment of Patients With Poor Performance Status (ECOG 3-4)

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Long Term Survival in 200 Patients With Advanced Stage of Colorectal Carcinoma and Diabetes Mellitus – A Single Institution Experience

Radiology and Oncology
Nuclear MedicineRadiologyImagingOncology
2019English

Long-Term Survival in Working-Age Patients After Cerebrovascular Accident

Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova
PsychiatryMental HealthNeurology
2016English

A Phase I Study of Midostaurin and Azacitidine in Relapsed and Elderly AML Patients

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2015English

Outcomes and Survival on Long Term Intravenous Inotrope Therapy: A Single Center Experience

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2017English

Long-Term Survival Strategy for the Pharmacy Profession

Drug Intelligence & Clinical Pharmacy
1985English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy